Investment Intern - Life Sciences - Dementia Team - Amsterdam

EQT Life Sciences is seeking a curious and analytically minded Investment Intern to join our Amsterdam-based neuroscience investment team for a period of six months. This is a hands-on opportunity to contribute to neuroscience investing at one of Europe's most experienced specialist investors, gaining meaningful exposure across the full investment cycle.

EQT Life Sciences, formerly LSP, has spent over 30 years backing companies at the frontier of human health. We invest in therapeutics, medical devices, diagnostics and healthtech globally, and have raised around €3.5 billion across 12 private funds and three investment strategies. we have backed 150 companies and brought over 100 medications and technologies on the market to patients. Our team brings together professionals from medicine, science and industry, united by a shared belief that the right capital, paired with deep scientific expertise, can genuinely change outcomes for patients. One of these strategies exclusively invests in therapeutics, diagnostics and technologies working to prevent, diagnose and treat dementia and other neurodegenerative diseases, among the greatest unmet needs in medicine today.

As an Investment Intern, you will work closely alongside our investment professionals in Amsterdam, contributing to real work across the full breadth of our activity, from identifying new opportunities to supporting due diligence and engaging with portfolio companies. This role is designed to give you meaningful, practical exposure to how life sciences investment decisions are made.

• Screen and assess new investment opportunities in dementia and neurodegeneration, spanning therapeutics, diagnostics, medical devices and enabling technologies


• Contribute to scientific, clinical and commercial due diligence on prospective investments


• Conduct market research, competitive analysis and reviews of the scientific literature


• Help prepare investment materials and internal analyses to support the team's decision-making


• Collaborate closely with senior investment professionals on live transactions and portfolio work


• Gain direct exposure to portfolio companies operating at the frontier of neuroscience research

You are intellectually curious, analytically grounded and genuinely excited about the intersection of science and investment. You communicate complex ideas clearly, take ownership of your work and contribute thoughtfully in a collaborative setting.

• A Master's degree in a life sciences discipline, such as neuroscience , medicine, pharmacy, chemistry, biology or a related field
• At least two years of relevant experience beyond your undergraduate studies, whether through professional work, a PhD programme or advanced postgraduate study
• Experience reading and critically appraising clinical or scientific literature
• A strong interest in scientific innovation and how novel discoveries translate into medicines or medical technologies
• Proven ability to synthesise complex scientific information and present it clearly, both in writing and in conversation
• Fluency in English, written and spoken
• A proactive, collaborative working style with the ability to take ownership and manage your own workload

• Familiarity with the life sciences investment landscape or prior exposure to a healthcare or biotech environment
• A background or demonstrable interest in neuroscience, neurology or neurodegenerative diseases
• Additional European language skills

• Practical, meaningful exposure to life sciences investing at one of Europe's leading specialist firms
• Close mentorship from investment professionals with deep backgrounds in medicine, science and industry
• Broad experience across neuroscience, from therapeutics and diagnostics to digital and enabling technologies, including engagement with companies at the frontier of their fields
• An international, intellectually stimulating and collaborative environment, supported by the wider EQT platform
• A flexible start date and an internship duration of five to nine months

_EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of over three decades of developing companies across multiple geographies, sectors and strategies. EQT has investment strategies covering all phases of a business’ development, from start-up to maturity. EQT has EUR ‌​​270 billion in total assets under management (EUR ‌​​‌141 billion in fee-generating assets under management), within two business segments – Private Capital and Real Assets.

_More info: [
Follow EQT on [LinkedIn]( [X]( [YouTube]( B1Okw/featured) and [Instagram](